SCHEMBL1015897

SCHEMBL1015897

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)Nc1cccc(-c2cnco2)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 1/20 0.49
IMPDH2 P12268 6/20 0.44
PORCN Q9H237 1/20 0.43
ROCK2 O75116 1/20 0.43
ROCK1 Q13464 1/20 0.43
BRAF P15056 2/20 0.42
SERPINE1 P05121 1/20 0.42
PFKFB3 Q16875 1/20 0.42
PFKFB4 Q16877 1/20 0.42
AAK1 Q2M2I8 1/20 0.41
CCR9 P51686 2/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.40
RAF1 P04049 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1012978 0.91 SERPINE1 (0.51) EDNRAIMPDH2PORCNBRAFSERPINE1
SCHEMBL1016295 0.86 LCLAT1 (0.49) SERPINE1NPC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL1013377 0.85 SERPINE1 (0.43) SERPINE1NPC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL1016339 0.84 CNR1 (0.53) SERPINE1ALDH1A1MEN1KMT2AKDM4E
SCHEMBL1015635 0.84 CNR1 (0.51) SERPINE1AAK1SMN1; SMN2MEN1KMT2A
SCHEMBL1016790 0.82 SERPINE1 (0.47) SERPINE1NPC1ALDH1A1SMN1; SMN2MEN1
SCHEMBL1012911 0.82 MEN1 (0.44) ROCK2ROCK1SERPINE1MEN1KMT2A
SCHEMBL1016524 0.81 NPC1 (0.46) SERPINE1NPC1ALDH1A1HPGDSMN1; SMN2
SCHEMBL1016282 0.81 SERPINE1 (0.47) SERPINE1NPC1ALDH1A1SMN1; SMN2MEN1
SCHEMBL1015662 0.81 SERPINE1 (0.64) SERPINE1NPC1ALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 EDNRA 1566/4885IMPDH2 3416/4885PORCN 2253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.